Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TODINELI Trial
2013-004375-12Phase 2Completed
- Sponsor
- Mech-Sense
- Start
- Feb 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of liraglutide in diabetes mellitus type 1 (T1D) and diabetic polyneuropathy (DPN), sponsored by Mech-Sense. Primary endpoint: Alterations in electrophysiological profile. Started Feb 2014; status: completed.
02
Drugs
03
Conditions
diabetes mellitus type 1 (T1D)diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2013-004375-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004375-12.